Cancer research has entered a new era with the advent of patient-derived organoids (PDOs). These sophisticated three-dimensional (3D) models, grown from patient cells, have revolutionized our understanding of tumors and their microenvironments. By mimicking the complexity of human tumors, PDOs have
AstraZeneca has recently submitted a Biologics License Application (BLA) to the FDA for datopotamab deruxtecan (Dato-DXd), targeting accelerated approval for adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) that possess EGFR mutations. This submission is a significant
Comprehensive Genomic Profiling (CGP) is revolutionizing cancer treatment by enabling early detection and personalized therapy. A recent study published in the Journal of Clinical Oncology - Oncology Practice (JCO-OP) highlights the significant benefits of early CGP testing in improving clinical
Advancements in cancer diagnosis and treatment have significantly improved survival rates, leading to a growing number of young cancer survivors. This demographic shift brings unique challenges as these individuals navigate life post-treatment, facing physical, emotional, and social upheavals. The
Breast Cancer Awareness Month has highlighted a pressing health crisis among Indian women, particularly those aged 55 to 64. A recent report by Healthians reveals that 16% of women in this demographic are affected by breast cancer. This alarming statistic underscores the urgent need for awareness,
The recent approval of Aucatzyl by the FDA marks a significant advancement in the treatment landscape for patients with B-cell precursor acute lymphoblastic leukemia, especially those whose disease has progressed following initial chemotherapy treatments. Developed by U.K.-based Autolus